Vigabatrin Oral Solution 500mg Recalled: What Patients and Providers Need to Know

on

**Important Information:** On December 9, 2023, InvaGen Pharmaceuticals issued a voluntary nationwide recall of one lot of Vigabatrin for Oral Solution, USP 500mg, due to potential leaking sachets. This issue could pose a risk to patients and requires immediate action.

**What's the problem?** The recalled lot (NB301030) has been found to have seal integrity issues, meaning the powder inside the sachets may leak. This could lead to:

* **Reduced dosage:** Leaking can result in inaccurate and potentially ineffective doses.

* **Contamination:** The powder could become contaminated by external substances.

* **Skin irritation:** Contact with the powder may cause skin irritation or allergic reactions.

**Who is affected?** This recall only affects Vigabatrin for Oral Solution, USP 500mg, with lot number NB301030. If you are unsure about the lot number of your medication, please check the packaging or contact your pharmacist.

**What should you do?**

* **Patients:** If you are taking Vigabatrin for Oral Solution, USP 500mg, with lot number NB301030, **stop taking the medication immediately**. Contact your doctor or pharmacist for instructions on returning the recalled product and obtaining alternative treatment.

* **Healthcare providers:** Discontinue dispensing the recalled lot of Vigabatrin for Oral Solution, USP 500mg, and advise patients to stop taking the medication. Inform affected patients about the recall and provide instructions on returning the product and obtaining alternative treatment.

**Additional Information:**

* You can find more information about the recall on the FDA website:

 https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/invagen-pharmaceuticals-issues-voluntary-nationwide-recall-vigabatrin-oral-solution-usp-500mg-due

* For further questions or concerns, contact InvaGen Pharmaceuticals at 1-877-468-2436.

**Please share this information with anyone you know who may be taking Vigabatrin for Oral Solution, USP 500mg, especially those with the affected lot number.** This recall is important to ensure patient safety and prevent potential harm.

**Note:** This article is for informational purposes only and should not be construed as medical advice. Always consult your doctor or pharmacist for personalized guidance regarding your medication.

Source 😀 bard.google.com

Comments

Post a Comment